This is a routine public awareness campaign with no financial data, no immediate trading catalyst. Monitor for future earnings or contract announcements that may quantify the commercial impact of naloxone product sales.
EBS drugs
EBS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 4 $8.44entry
- T+1 · 6mo ago −4.38%α −1.79% · $8.07
- T+5 · 5mo ago −0.59%α +1.96% · $8.39
- T+20 · 4mo ago −1.90%α −0.52% · $8.28
- T+60 · 3mo ago −29.98%α −31.86% · $5.91
Price Chart
How similar events traded
Executive Summary
Emergent BioSolutions issued a press release announcing its partnership with Victoria's Voice Foundation for National Naloxone Awareness Day and promoting its NARCAN Nasal Spray and KLOXXADO products. The release is primarily a public awareness and branding initiative with no new financial data, contracts, or material business developments disclosed.
Key Facts
- Emergent is the presenting sponsor of National Naloxone Awareness Day on June 6, 2026, in partnership with Victoria's Voice Foundation.
- The company is continuing its 'Ready to Rescue' initiative at colleges and universities with spokesperson Zac Clark.
- Emergent is the leading U.S. supplier of nasal naloxone, offering NARCAN Nasal Spray 4 mg (OTC) and KLOXXADO Nasal Spray 8 mg (prescription).
- No financial figures, revenue, earnings, guidance, or deal values were disclosed in the press release.
Financial Impact
No financial impact disclosed or estimable from the press release content.
Risk Factors
- Opioid overdose reversal market faces potential pricing pressure and regulatory changes.
- Competition from generic naloxone products could erode market share.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3306708 |
Track record
23 reports on EBS
4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +14.89% at T+20 after the Apr 29, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today Institutional Cluster Neutral 3/10 Entry $5.76 Now $5.81 +0.96% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.75 Now $5.81 +1.13% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.79 Now $5.81 +0.35% settles Nov 23
- Nov 4, 202612d ago 8-K Neutral 4/10 Entry $5.85 to $5.89 Now $5.81 −0.68% ▲ +0.68% −2.61% vs SPY
- Nov 2, 202614d ago 8-K Bearish 6/10 Entry $6.25 to $6.05 Now $5.81 +7.04% ▲ +3.20% +2.61% vs SPY
- Oct 30, 202617d ago Institutional Cluster Neutral 2/10 Entry $6.81 to $6.06 Now $5.81 −14.68% ▼ −11.01% −8.31% vs SPY
- Oct 16, 20264w ago 8-K Neutral 3/10 Entry $6.38 to $6.23 Now $5.81 −8.93% ▼ −2.35% −2.44% vs SPY
- Oct 7, 20265w ago 144 Neutral 2/10 Entry $6.81 to $7.18 Now $5.81 −14.68% ▲ +5.43% +5.71% vs SPY
- Jun 29, 202620w ago 8-K Bullish 5/10 Entry $8.46 to $8.18 Now $5.81 −31.32% ▼ −3.31% −4.70% vs SPY
- Jun 4, 202623w ago Press Release Neutral 2/10 Viewing Entry $8.44 to $8.39 Now $5.81 −31.16% ▼ −0.59% +1.96% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers